December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chimerix, Inc. - Common Stock (NQ:CMRX)

8.540 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chimerix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Appoints Lisa Decker to Board of Directors
Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience 
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
Proven Leader Brings More Than 25 Years of Financial Experience 
From Chimerix, Inc.
Via GlobeNewswire
Earnings Outlook For Chimerix
 
Via Benzinga
4 Analysts Have This to Say About Chimerix
 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
Chimerix Earnings Preview
 
Via Benzinga
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
Seasoned Executive Brings More Than 25 Years of Industry Leadership Experience in Oncology Commercialization and Corporate Business Development 
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
From Chimerix, Inc.
Via GlobeNewswire
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
Chimerix to Participate in Upcoming Investor Conferences
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
From Chimerix, Inc.
Via GlobeNewswire
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech. 
Via InvestorPlace
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns. 
Via InvestorPlace
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
From Chimerix, Inc.
Via GlobeNewswire
7 Small-Cap Stocks to Buy Before the Breakout
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
Via InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. 
Via InvestorPlace
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
From Chimerix, Inc.
Via GlobeNewswire
7 Deeply Undervalued Growth Stocks to Buy in June
Investors may see significant rewards betting on these best undervalued growth stocks for June. 
Via InvestorPlace
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
Forum Aim is to Share Progress and Spur Actions to Advance the Field 
From Chimerix, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
 
Via Benzinga
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
From Chimerix, Inc.
Via GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.